| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.9M | +19.9% | +112.3% |
| Cost of Revenue | $4.4M | +3.4% | +88.0% |
| Gross Profit | $2.5M | +65.7% | +173.8% |
| R&D Expense | $115K | -62.6% | -71.0% |
| SG&A Expense | $3.3M | -22.9% | +65.5% |
| Operating Income | -$1.1M | +67.6% | +41.9% |
| Net Income | -$1.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $136K | -40.2% | -91.5% |
| Inventory | $504K | -1.1% | -51.0% |
| Current Assets | $37.2M | +679.8% | +755.2% |
| Total Assets | $69.8M | +124.2% | +216.9% |
| Current Liabilities | $9.7M | -26.0% | +62.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.0M | — | — |
| Capital Expenditures | $7.8M | — | — |
| Investing Cash Flow | -$7.9M | — | — |
| Financing Cash Flow | $45.8M | — | — |
| Free Cash Flow | -$18.8M | — | — |
| +70.4% |
| +25.8% |
| EPS (Basic) | -$0.06 | +80.0% | +66.7% |
| EPS (Diluted) | -$0.06 | +80.0% | +66.7% |
| $20.3M |
| -23.1% |
| +4.0% |
| Stockholders' Equity | $49.5M | +946.0% | +1870.2% |